Recent research regarding the expression of endoplasmic reticulum resident protein 57 (ERp57) in tumors revealed that ERp57 expression is upregulated in various cancers and participates in cancer initiation, progression and chemosensitivity 3-5. This evidence concerns the gene PDIA3 and cancer.